Hester Biosciences to receive Rs 60 crore grant from BIRAC for COVID vaccine manufacturing
New Delhi: Hester Biosciences on Thursday said it will receive a Rs 60-crore grant from Biotechnology Industry Research Assistance Council (BIRAC) to support COVID-19 vaccine manufacturing.
''The company's board has approved execution of grant-in-aid letter agreement for a grant of Rs 60 crore (in phased manner) to the drug maker by BIRAC under Mission COVID Suraksha,'' Hester Biosciences said in a regulatory filing.
Read also: Hester India to acquire 50 percent stake in Thrishool Exim for Rs 16 crore
Last year, a Memorandum of Understanding was inked between Bharat Biotech and Gujarat COVID Vaccine Consortium (GCVC) for the production of Covaxin.
GCVC comprises Gujarat Biotechnology Research Centre, Hester Biosciences and OmniBRx Biotechnologies.
Read also: Hester Biosciences Limited ventures into Pet Care Industry
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.